• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

125I标记的巴曲酶在大鼠和犬体内的代谢命运。

Metabolic fate of 125I-labeled batroxobin in rats and dogs.

作者信息

Sugai K, Imamura Y, Mihashi S, Mori N, Baba S

出版信息

J Toxicol Sci. 1986 Aug;11(3):155-67. doi: 10.2131/jts.11.155.

DOI:10.2131/jts.11.155
PMID:3540318
Abstract

125I-Labeled batroxobin was prepared and following its intravenous and subcutaneous administrations to rats and dogs, the blood radioactivity was determined. In the both species following the intravenous injections, the decrease in radioactivity was biexponential. Following subcutaneous administration, radioactivity became maximal at 6h and decreased in a manner similar to that of the beta-phase of the intravenous injection. The blood concentration of fibrinogen in dogs was also determined. After the intravenous injection, fibrinogen became undetectable 1h later, and appeared again in the blood at 24h. After the subcutaneous injection, the decrease was not so rapid. Fibrinogen resumed its original levels at 7 day after the administration in both the routes. Radioactivity after the both injections was excreted generally in the urine in about the same amounts. The total urinary and fecal excretions in rats and dogs were 80 and 95%, respectively. The distribution of radioactivity in the tissues was examined by counting technique and whole-body autoradiography. Radioactivity predominantly accumulated in the thyroid and stomach and could also be found in the kidneys and liver in fair amounts. The distribution patterns of radioactivity for both the routes of administrations and also for male and pregnant rats were basically the same. In fetus rats, a slight distribution was noted. From the results of gel filtration chromatography and trichloroacetic acid fractionation, [125I] batroxobin was metabolized soon after the administration to afford low molecular substances such as 125I-ion in the plasma and urine.

摘要

制备了125I标记的巴曲酶,并在对大鼠和犬进行静脉内和皮下给药后,测定了血液放射性。在这两个物种中,静脉注射后放射性的下降呈双指数形式。皮下给药后,放射性在6小时达到最大值,并以类似于静脉注射β相的方式下降。还测定了犬的血液纤维蛋白原浓度。静脉注射后,1小时后纤维蛋白原无法检测到,并在24小时再次出现在血液中。皮下注射后,下降没有那么快。两种给药途径在给药7天后纤维蛋白原恢复到原始水平。两种注射后的放射性一般以大致相同的量经尿液排出。大鼠和犬的尿液和粪便总排泄量分别为80%和95%。通过计数技术和全身放射自显影检查了组织中的放射性分布。放射性主要积聚在甲状腺和胃中,也可以在肾脏和肝脏中大量发现。两种给药途径以及雄性和妊娠大鼠的放射性分布模式基本相同。在胎鼠中,有轻微的分布。从凝胶过滤色谱和三氯乙酸分级分离的结果来看,[125I]巴曲酶在给药后很快被代谢,在血浆和尿液中产生低分子物质,如125I离子。

相似文献

1
Metabolic fate of 125I-labeled batroxobin in rats and dogs.125I标记的巴曲酶在大鼠和犬体内的代谢命运。
J Toxicol Sci. 1986 Aug;11(3):155-67. doi: 10.2131/jts.11.155.
2
Plasma levels and urinary excretion of batroxobin and its defibrinogenating effects in various animal species.巴曲酶在不同动物物种中的血浆水平、尿排泄及其去纤维蛋白原作用
J Toxicol Sci. 1986 May;11(2):135-43. doi: 10.2131/jts.11.135.
3
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.4-乙酰氨基苯乙酸的药代动力学。首次通讯:单次给予14C标记化合物后在小鼠、大鼠、狗和猴体内的吸收、分布、代谢及排泄情况
Arzneimittelforschung. 1990 Jul;40(7):800-5.
4
Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats.达比加群酯的药代动力学研究:大鼠单次静脉注射和皮下注射后的吸收、分布及排泄
Xenobiotica. 2007 Jan;37(1):74-90. doi: 10.1080/00498250600987929.
5
Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice.人活化蛋白C的药代动力学。第二次通讯:雄性小鼠单次或重复静脉给药后冻干纯化的人活化蛋白C的组织分布研究以及怀孕和哺乳期小鼠静脉给药后的胎盘转运和乳汁传递研究。
Arzneimittelforschung. 1995 May;45(5):644-56.
6
The metabolism and kinetics of 125I-labeled human intravenous IgG preparation (C-425) in rats and rabbits. I. Blood clearance, excretion into urine and feces, and brain uptake.125I标记的人静脉注射免疫球蛋白制剂(C-425)在大鼠和兔子体内的代谢与动力学。I. 血液清除率、尿和粪便排泄以及脑摄取。
Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):35-42. doi: 10.1007/BF03190840.
7
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
8
Metabolic fate of diltiazem. Distribution, excretion and protein binding in rat and dog.地尔硫䓬的代谢命运。大鼠和犬体内的分布、排泄及蛋白结合情况。
Arzneimittelforschung. 1987 Nov;37(11):1244-52.
9
Defibrinogenation with benzoyl-batroxobin.
Thromb Res. 1985 Oct 1;40(1):41-7. doi: 10.1016/0049-3848(85)90348-2.
10
Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.马来酸2,4-二氨基-6-(2,5-二氯苯基)-s-三嗪在大鼠、狗和猴体内的吸收、分布及排泄
Arzneimittelforschung. 1986 Aug;36(8):1221-8.